Category: Diagnostics
Global Diagnostics
-
Breast Imaging Technologies
... at a CAGR of 5.2% over the analysis period 2024-2030. Ionizing Technologies, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$3.3 Billion by the end of ... Read More
-
Dengue Testing
... CAGR of 4.8% over the analysis period 2024-2030. ELISA-Based Tests, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$383.2 Million by the end of the analysis ... Read More
-
Digital X-ray
... CAGR of 6.3% over the analysis period 2024-2030. Direct Radiography, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$12.3 Billion by the end of the analysis ... Read More
-
Infectious Disease Diagnostics
... at a CAGR of 5.5% over the analysis period 2024-2030. Assays & Reagents, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$25.8 Billion by the end ... Read More
-
Anatomic Pathology
... CAGR of 5.8% over the analysis period 2024-2030. Anatomic Pathology Services, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$36.4 Billion by the end of the ... Read More
-
Blood Transfusion Devices
... at a CAGR of 5.8% over the analysis period 2024-2030. Pathogen Reduction System, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$3.7 Billion by the end ... Read More
-
CBCT / Cone Beam Imaging
... Billion by 2030, growing at a CAGR of 8.5% over the analysis period 2024-2030. Standing Patient Position, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$968.6 ... Read More
-
Heavy Metal Testing
... at a CAGR of 4.7% over the analysis period 2024-2030. Arsenic Testing, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$2.1 Billion by the end of ... Read More
-
Industrial Computed Tomography Equipment
... 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Equipment Offering, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$485.4 Million by the ... Read More
-
Mobile MRI Services
... at a CAGR of 3.5% over the analysis period 2024-2030. Oncology Application, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$1.3 Billion by the end of ... Read More
-
Surgical Imaging Technologies
... at a CAGR of 2.7% over the analysis period 2024-2030. Image Intensifier C-arms, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$3.4 Billion by the end ... Read More
-
Thyroid Function Tests
... at a CAGR of 4.0% over the analysis period 2024-2030. TSH Tests, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$1.2 Billion by the end of ... Read More
-
Refurbished Medical Equipment
... at a CAGR of 11.1% over the analysis period 2024-2030. Medical Imaging Equipment, one of the segments analyzed in the report, is expected to record a 12.3% CAGR and reach US$13.3 Billion by the end ... Read More
-
Cervical Dysplasia Diagnostics
... at a CAGR of 5.9% over the analysis period 2024-2030. Diagnostic Tests, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$793.8 Million by the end of ... Read More
-
STD Testing
... CAGR of 5.2% over the analysis period 2024-2030. Chlamydia, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$40.6 Billion by the end of the analysis period. ... Read More
-
Blood Transfusion Diagnostics
... at a CAGR of 4.7% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.7 Billion by the end of the ... Read More
-
Radiofrequency Ablation Devices for Pain Management
... reach US$1.4 Billion by 2030, growing at a CAGR of 9.9% over the analysis period 2024-2030. Disposable Products, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach ... Read More
-
Tissue Diagnostics
... CAGR of 6.6% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$8.4 Billion by the end of the analysis period. ... Read More
-
Veterinary Hematology Analyzers
... at a CAGR of 5.3% over the analysis period 2024-2030. Table Top Analyzers, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.2 Billion by the end ... Read More
-
Fluoroscopy and Mobile C-Arms
... 2030, growing at a CAGR of 3.8% over the analysis period 2024-2030. Fluoroscopy, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$2.2 Billion by the end ... Read More
-
3D Medical Imaging
... at a CAGR of 6.1% over the analysis period 2024-2030. CT Devices, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$8.9 Billion by the end of ... Read More
-
Flat Panel X-Ray Detectors
... 2030, growing at a CAGR of 4.6% over the analysis period 2024-2030. Manufacturing, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$741.3 Million by the end ... Read More
-
Antithrombin
... 5.3% over the analysis period 2024-2030. Therapeutics, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$847.5 Million by the end of the analysis period. Growth in ... Read More
-
Hematology Diagnostics
... CAGR of 5.8% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$7.8 Billion by the end of the analysis period. ... Read More
-
X-Ray Tubes
... CAGR of 3.9% over the analysis period 2024-2030. Healthcare, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$3.0 Billion by the end of the analysis period. ... Read More